Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03675776
Recruitment Status : Recruiting
First Posted : September 18, 2018
Last Update Posted : May 23, 2019
Sponsor:
Information provided by (Responsible Party):
Naurex, Inc, an affiliate of Allergan plc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 25, 2020
  Estimated Study Completion Date : December 25, 2020